$SISI News

Last published 1y ago

1y agoSISIShineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual EnginesPR NewswireShineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a developer and commercializer of induced pluripotent stem cell (iPSC) technology...
1y agoSISIShineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across IndustriesPR NewswireShineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today...
1y agoSISIShineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term GrowthPR NewswireShineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered...
1y agoSISIShineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech NetworkPR NewswireShineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a leading innovator in induced pluripotent stem cell (iPSC) technology, today announced the...
1y agoSISIShineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain TechnologyPR NewswireShineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced ...
1y agoSISIShineco, Inc. to Effect 50:1 Reverse Stock SplitGlobeNewswireMeasure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price BEIJING, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (NASDAQ:SISI) ("Shineco" or the "Company"), a provider of
1y agoSISIManagement Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase ProgramGlobeNewswireBEIJING, June 11, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced
1y agoSISIShineco's Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare MarketGlobeNewswireBEIJING, May 13, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced
1y agoSISIShineco Announces Acquisition of Singapore Evolutionary Stem Cell CompanyGlobeNewswireExpanding the Frontiers of Regenerative Medicine BEIJING, April 23, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a provider of innovative diagnostic medical
1y agoSISIShineco Announces Acquisition of Medical Device CompanyGlobeNewswireThe Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a
1y agoSISIShineco Announces Reverse Split to Regain NASDAQ ComplianceGlobeNewswireBEIJING, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that effective at
2y agoFTFT SISIFuture FinTech Announces the Appointment of Hu Li as the New CEOPR NewswireFuture Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and...
2y agoSISIShineco Announces Closing of $2 Million Underwritten Public OfferingGlobeNewswireBeijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its
2y agoSISIShineco Announces Pricing of $2 Million Underwritten Public OfferingGlobeNewswireBeijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its
2y agoSISIShineco Announces Proposed Underwritten Public OfferingGlobeNewswireBeijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an
2y agoSISIShineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food BeverageGlobeNewswireThe Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company",
2y agoSISIShineco Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireBEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5,
2y agoSISIShineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 MillionGlobeNewswireBEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20,
2y agoSISIShineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging PopulationGlobeNewswireBEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. ("Shineco" or the "Company"; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024,
2y agoSISIShineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care ProductsGlobeNewswireBeijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14,
2y agoSISIShineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care IndustryPR NewswireShineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today...
2y agoSISIShineco Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireBEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that on March 11, 2024, the
2y agoSISIShineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementGlobeNewswireBEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that the Company's Board of
2y agoSISIShineco Announces the Appointment of Two New Executive OfficersGlobeNewswireBEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors
3y agoSISIShineco Opens Healthy Food Restaurant with Focus on Advanced NutritionGlobeNewswireSISI Anticipates the Roll-Out of Additional Restaurants to Develop a Chain of Healthy Food Restaurants BEIJING, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of
3y agoSISIShineco to Increase R&D to Explore New High-Tech Medical Product ApplicationsGlobeNewswireThe Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products BEIJING, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or
3y agoSISIShineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute TestGlobeNewswireRegistration with the NMPA, China's Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution BEIJING, July 10, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company",
3y agoSISIShineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products CompanyGlobeNewswireBEIJING, June 28, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that on June 15, 2023, its
3y agoSISIShineco Subsidiary Registered as a Member of Pharmaceutical Chamber of CommerceGlobeNewswireAssociation with the Chamber Will Improve Visibilityand Could Lead to Potential Collaborations BEIJING, June 08, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of
3y agoSISIShineco Subsidiary's 'Cardiac 5-Minute Test' Passes Quality Inspection by China Regulator NMPAGlobeNewswireApproval Provides Strong Support for the Product's Marketing in China BEIJING, April 04, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese
3y agoSISIShineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus GroupGlobeNewswireBEIJING, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural products and other biotech products,
3y agoSISIShineco, Inc. Subsidiary Receives Prior Approval Supplement from the NMPA Jiangsu Bureau for the Marketing Approval of "Cardiac 5-Minute Test"GlobeNewswireBEIJING, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced
3y agoSISIShineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling DeviceGlobeNewswireBEIJING, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc.(("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced
3y agoSISIShineco, Inc. Attends MEDICA 2022 Düsseldorf GermanyGlobeNewswireBEIJING, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced
4y agoSISIShineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing IndustryGlobeNewswireBEIJING, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc.(("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced
4y agoSISIShineco, Inc. Announces Director ChangeGlobeNewswireBEIJING, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, today announced that on August 17, 2022, the b
4y agoSISIShineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 MillionGlobeNewswireBEIJING, April 14, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a securiti
4y agoSISIShineco, Inc. Announces Board and Officer ChangesGlobeNewswireBEIJING, March 28, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, today announced the board of directors (the "
4y agoSISIShineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business TransitionGlobeNewswireBEIJING, March 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced the Company has signed a fund estab
4y agoSISIShineco, Inc. to Build Its First Tumor Classification Diagnosis and Treatment Center in Weifang City, Shandong ProvinceGlobeNewswireBEIJING, March 11, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on March 4, 2022, the Company
4y agoSISIShineco, Inc. Announces New Website LaunchGlobeNewswireBEIJING, March 03, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced the launch of its redesigned websit
4y agoSISIShineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor PatientsGlobeNewswireBEIJING, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company entered into a stra
4y agoSISIShineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical DevicesGlobeNewswireBEIJING, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on February 16, 2022, the Compa
4y agoSISIShineco, Inc. Enters Into Cooperation Agreement to Jointly Manufacture PET and Explore High-end Medical Imaging Devices FieldGlobeNewswireBEIJING, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on January 30, 2022, the Compan
4y agoSISIShineco, Inc. Appoints Professor Qiyin Sun as Chief Medical ConsultantGlobeNewswireBEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company has appointed Profe
4y agoSISIShineco, Inc. Enters Into Share Transfer Agreements to Acquire 51% Equity Interest in Xiang Peng You Kang (Beijing) Technology Co., Ltd.GlobeNewswireBEIJING, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on January X, 2022, the Compan
4y agoSISIShineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USDGlobeNewswireBEIJING, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a securitie
4y agoSISIShineco, Inc. Intends to Acquire a Controlling Interest of Xiang Peng You Kang (Beijing) Technology Co., Ltd., a Healthcare Services CompanyGlobeNewswireAs a Preemptive Action to Develop Comprehensive Medical and Healthcare Services BEIJING, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agr